416 related articles for article (PubMed ID: 8970501)
1. Health-economic implications of the onset of action of antimanic agents.
Keck PE; McElroy SL; Bennett JA
J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
[TBL] [Abstract][Full Text] [Related]
2. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
Keck PE; Nabulsi AA; Taylor JL; Henke CJ; Chmiel JJ; Stanton SP; Bennett JA
J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
[TBL] [Abstract][Full Text] [Related]
3. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
5. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
6. A medication algorithm for treatment of bipolar rapid cycling?
Calabrese JR; Woyshville MJ
J Clin Psychiatry; 1995; 56 Suppl 3():11-8. PubMed ID: 7883737
[TBL] [Abstract][Full Text] [Related]
7. The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.
Dilsaver SC; Swann AC; Shoaib AM; Bowers TC
J Psychiatry Neurosci; 1993 Mar; 18(2):61-6. PubMed ID: 8461283
[TBL] [Abstract][Full Text] [Related]
8. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
[TBL] [Abstract][Full Text] [Related]
9. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
10. Dosing strategies and time course of response to antimanic drugs.
Bowden CL
J Clin Psychiatry; 1996; 57 Suppl 13():4-9; discussion 10-2. PubMed ID: 8970500
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy in bipolar I disorder.
Solomon DA; Keitner GI; Ryan CE; Miller IW
Psychopharmacol Bull; 1996; 32(4):579-87. PubMed ID: 8993078
[TBL] [Abstract][Full Text] [Related]
12. Non-lithium treatment for bipolar disorder.
Post RM
J Clin Psychiatry; 1990 Aug; 51 Suppl():9-16; discussion 17-9. PubMed ID: 2116406
[TBL] [Abstract][Full Text] [Related]
13. [Valproate in the treatment of bipolar disorder].
Rzewuska M
Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
[TBL] [Abstract][Full Text] [Related]
14. Rapid cycling bipolar disorder and its treatment with valproate.
Calabrese JR; Rapport DJ; Kimmel SE; Reece B; Woyshville MJ
Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S57-61. PubMed ID: 8500080
[TBL] [Abstract][Full Text] [Related]
15. Disodium valproate: new preparation. An alternative for acute mania after lithium failure or intolerance.
Prescrire Int; 2001 Aug; 10(54):113-5. PubMed ID: 11718180
[TBL] [Abstract][Full Text] [Related]
16. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
17. Decision model for the acute treatment of mania.
Steffens DC; Krishnan KR
Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657
[TBL] [Abstract][Full Text] [Related]
18. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to divalproex and lithium.
Bowden CL
J Clin Psychiatry; 1995; 56 Suppl 3():25-30. PubMed ID: 7883739
[TBL] [Abstract][Full Text] [Related]
20. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
